Tong Ming Liu | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Dr. Tong Ming Liu |  Stem Cell Research | Best Researcher Award

Institute of Molecular and Cell Biology | Singapore

Dr. Tong Ming Liu’s research focuses on advancing gene and cell therapy through innovative studies on human mesenchymal stem cells (hMSCs) and induced pluripotent stem cells (iPSCs). His work explores the mechanisms governing mesenchymal stem cell stemness, potency, and ageing, with the goal of improving the therapeutic efficacy and manufacturing quality of MSC-based treatments. A central aspect of his research is identifying and characterizing critical quality attributes (CQAs) in MSC manufacturing to ensure consistent and safe clinical applications. Dr. Liu also investigates disease modeling of bone and cartilage disorders using iPSC-derived MSCs to facilitate drug screening and gene correction strategies. His recent projects include the development of optimized media for iPSC, iPSC-MSC, and MSC culture, as well as identifying novel biomarkers to select high-quality MSCs for regenerative medicine. Through his studies, he aims to enhance the scalability, functionality, and translational potential of stem cell therapies. His findings have been recognized in scientific forums such as the EVANTICA Symposium and Singapore Cell and Gene Therapy Conference, underscoring his contribution to the development of efficient MSC-derived extracellular vesicle (MSC-EV) optimization and regenerative therapy innovations.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications:

Liu, T. M.*, Tew, W., Yang, Z., Lim, B., Hui, J. H. P., Lee, E. H., Loh, Y.-H., & Cool, S. (2025). Understanding the molecular basis of mesenchymal stem cell stemness: Implications for clinical applications. Cell Death & Disease, 16(1), 778.

Liu, T. M.* (2025). MSC-EVs: Pioneering the next generation of biomedical applications. World Journal of Stem Cells, 17(6), 108197.

Liu, T. M.*, & Wu, Y. (2023). Advancing gene and cell therapy using human mesenchymal stem cells. Frontiers in Cell and Developmental Biology, 11, 1294460.

Shou, Y., Liu, L., Le, Z., Lee, K. L., Li, X., Koh, D. Z., Wang, Y., Liu, T. M., Yang, Z., Lim, C. T., Cheung, C., & Tay, A. (2023). Mechano-responsive hydrogel for directing stem cell manufacturing and therapy. Bioactive Materials, 24, 387–400.

Liu, T. M.* (2021). Application of mesenchymal stem cells derived from human pluripotent stem cells in regenerative medicine. World Journal of Stem Cells, 13(12), 1826–1844.

Srinivasan, A., Sathiyanathan, P., Yin, L., Liu, T. M., Lam, A., Ravikumar, M., Smith, R. A. A., Loh, H. P., Zhang, Y., Ling, L., Ng, S. K., Yang, Y. S., Lezhava, A., Hui, J., Oh, S., & Cool, S. M. (2022). Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion. Cytotherapy, 24(5), 456–472.

Liu, T. M.*, Yildirim, E. D., Li, P., Fang, H. T., Denslin, V., Kumar, V., Loh, Y.-H., Lee, E. H., Cool, S. M., Teh, B. T., Hui, J. H., Lim, B., & Shyh-Chang, N. (2020). Ascorbate and iron are required for the specification and long-term self-renewal of human skeletal mesenchymal stromal cells. Stem Cell Reports, 14(2), 210–225.

Hamidreza Mohammadi | Toxicology and Pharmacology | Best Researcher Award

Published on by Cell Biologist

Prof. Hamidreza Mohammadi | Toxicology and Pharmacology | Best Researcher Award

Mazandaran University of Medical Sciences, Sari, Iran

Dr. Hamidreza Mohammadi is a researcher specializing in toxicology, pharmacology, and nanomedicine, with extensive work focused on the toxicological and therapeutic applications of nanomaterials. His research spans multiple domains including nanotoxicology, polymer therapeutics, clinical and food toxicology, and the development of safer nanopharmaceuticals. He has contributed to advancing the understanding of how engineered nanomaterials interact with biological systems, emphasizing risk assessment, cellular mechanisms of toxicity, and strategies for biocompatibility improvement. Dr. Mohammadi’s studies also explore the design of polymer-based drug delivery systems with enhanced therapeutic efficacy and reduced side effects. His work integrates experimental and applied toxicology to bridge laboratory research with clinical practice, contributing to public health and safety in pharmacological sciences. With interdisciplinary expertise covering both environmental and clinical toxicology, his research aligns with global priorities in nanomedicine innovation and toxicological risk evaluation. His scholarly efforts continue to support the development of next-generation nanotherapeutics with optimized pharmacokinetics and minimized toxic responses, reinforcing the importance of safe and sustainable nanotechnology in medical and pharmaceutical applications.

Profile: Orcid

Featured Publications:

Mokhtari Azad, T., Mohammadi, H., Moosavi, A., Saadatmand, Z., & Nategh, R. (2004). Influenza surveillance in the Islamic Republic of Iran from 1991 to 2001. Eastern Mediterranean Health Journal, 10(3), 315–321.

Cheraghali, A. M., Mohammadi, H. R., Amirahmadi, M., Yazdanpanah, H., Abouhossain, G., & Zamanian, F. (2005). Incidence of patulin contamination in apple juice produced in Iran. Food Control, 16(2), 165–167.

Shafiee, H., Mohammadi, H., Rezayat, S. M., Hosseini, A., Baeeri, M., & Hassani, S. (2010). Prevention of malathion-induced depletion of cardiac cells mitochondrial energy and free radical damage by a magnetic magnesium-carrying nanoparticle. Toxicology Mechanisms and Methods, 20(9), 538–543.

Mohammadi, H., Karimi, G., Rezayat, S. M., Reza, A., Shafiee, H., & Nikfar, S. (2011). Benefit of nanocarrier of magnetic magnesium in rat malathion-induced toxicity and cardiac failure using non-invasive monitoring of electrocardiogram and blood pressure. Toxicology and Industrial Health, 27(5), 417–429.

Soltani, M., Shetab-Boushehri, S. F., Mohammadi, H., & Shetab-Boushehri, S. V. (2013). Proposing boric acid as an antidote for aluminium phosphide poisoning by investigation of the chemical reaction between boric acid and phosphine. Journal of Medical Hypotheses and Ideas, 7(1), 21–24.

Yi Zhang | Tumor Immunology | Best Researcher Award

Published on by Cell Biologist

Prof. Yi Zhang | Tumor Immunology | Best Researcher Award

The First Affiliated Hospital of Zhengzhou University | China

Prof. Yi Zhang is a globally recognized leader in genetically engineered cell therapy and translational immuno-oncology research. Over the past 36 years, he has made pioneering contributions to overcoming major barriers in cell therapy and advancing its clinical applications worldwide. His extensive research has produced 290 SCI-indexed publications, including 11 ESI top 1% highly cited papers, accumulating more than 14,000 citations and an h-index of 66. Prof. Zhang’s groundbreaking innovations include identifying the novel CAR-T therapeutic target CD276 for solid tumors, developing gene-editing technologies to reduce PD-1–mediated immunosuppression, and creating novel cytokines and culture protocols that enhance immune cell stemness and anti-tumor function. He has also led the development of CAR-T cells that normalize tumor vasculature and improve infiltration, significantly enhancing therapeutic efficacy. With 46 invention patents (17 authorized) and over 80 million yuan in technology transfers, his work bridges basic science and clinical application through an integrated “industry-university-research” platform. As principal investigator, he has directed more than 52 clinical trials—29 targeting solid tumors, the highest number globally—resulting in improved outcomes and even clinical cures for advanced cancer patients. His leadership in establishing national standards and safety protocols has also shaped the regulation and global best practices in cell therapy.

Profile: Orcid

Featured Publications:

Gao, Y., Liu, S., Huang, Y., Wang, H., Zhao, Y., Cui, X., Peng, Y., Li, F., & Zhang, Y. (2024, December 3). CAR T cells engineered to secrete IFNκ induce tumor ferroptosis via an IFNAR/STAT1/ACSL4 axis. Cancer Immunology Research.

Huang, Y., Cao, R., Wang, S., Chen, X., Ping, Y., & Zhang, Y. (2025, December 31). In vivo CAR-T cell therapy: New breakthroughs for cell-based tumor immunotherapy. Human Vaccines & Immunotherapeutics.

Li, J., Wang, D., Zhang, Z., Sun, K., Lei, Q., Zhao, X., Huang, J., Wang, L., & Zhang, Y. (2025, June 1). Serum carcinoembryonic antigen levels as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with colorectal cancer. The Journal of Immunology.

Lian, J., Yue, Y., Yu, W., & Zhang, Y. (2025, March 5). Correction: Immunosenescence: A key player in cancer development. Journal of Hematology & Oncology.

Ping, Y., Fan, Q., & Zhang, Y. (2025, February). Modulating lipid metabolism improves tumor immunotherapy. Journal for ImmunoTherapy of Cancer.

Hu, W., Li, F., Liang, Y., Liu, S., Wang, S., Shen, C., Zhao, Y., Wang, H., & Zhang, Y. (2025, January). Glut3 overexpression improves environmental glucose uptake and antitumor efficacy of CAR-T cells in solid tumors. Journal for ImmunoTherapy of Cancer.

Willa Hsueh | Immunometabolism | Best Researcher Award

Published on by Cell Biologist

Prof. Willa Hsueh | Immunometabolism | Best Researcher Award

The Ohio State University | United States

Dr. Willa Hsueh is a leading researcher in endocrinology, diabetes, and metabolism, with a career spanning several decades of pioneering contributions to hormone regulation and metabolic disease. Her early research provided key insights into renin biochemistry and aldosterone metabolism, particularly focusing on inactive “big renin” forms and their activation mechanisms in normal and pathological conditions such as diabetic nephropathy. Dr. Hsueh’s investigations have significantly advanced the understanding of the renin-angiotensin-aldosterone system (RAAS) and its role in blood pressure regulation, sodium balance, and endocrine disorders. Her studies explored adrenal physiology, steroid metabolism, and hormonal responses to physiological and pharmacological stimuli, laying the groundwork for later research on cardiovascular and metabolic dysfunctions in diabetes. Through her interdisciplinary approach combining endocrinology, nephrology, and metabolism, she has elucidated biochemical pathways linking hormonal imbalances to metabolic diseases. Dr. Hsueh continues to lead impactful research in diabetes and metabolic regulation, contributing to translational advancements that bridge molecular mechanisms with clinical applications for improved patient outcomes in endocrine and metabolic disorders.

Profiles: Scopus | Orcid

Featured Publications:

Hsueh, W. A., Boonjaren, S., Stein, J., Baehler, H. R., Osgood, R. W., Cohen, S., Yashon, D., & Ferris, T. (1974). Effect of plasma sodium concentration on diluting segment sodium reabsorption. Kidney International, 5(1), 1–11.

Johnson, K. R., Hsueh, W. A., Glusman, S. M., & Arnett, F. C. (1976). Fibrous myopathy: A rheumatic complication of drug abuse. Arthritis & Rheumatism, 19(5), 923–926.

Hsueh, W. A., & Hsu, T. H. (1978). Thyrotoxicosis in a patient with secondary hypothyroidism. Southern Medical Journal, 71(9), 1174–1177.

Hsueh, W. A., Luetscher, J. A., Carlson, E., & Grislis, G. (1978). Big renin in plasma of healthy subjects on high-sodium intake. The Lancet, 1(8077), 1281–1284.

Hsueh, W. A., Hsu, T. H., & Federman, D. D. (1978). Endocrine features of Klinefelter’s syndrome. Medicine, 57(5), 447–461.

Hsueh, W. A., Luetscher, J. A., Carlson, E., Grislis, G., Elbaum, D., & Chavarri, M. (1978). A comparison of cold and acid activation of big renin and of inactive renin in normal plasma. Journal of Clinical Endocrinology and Metabolism, 47(4), 792–799.

Charles Wang | Epigenomics | Distinguished Scientist Award

Published on by Cell Biologist

Prof. Charles Wang | Epigenomics | Distinguished Scientist Award

Prof. Charles Wang | Loma Linda University Center for Genomics | United States

Dr. Changhong Wang (now known as Dr. C. Wang), a U.S. citizen, is a distinguished molecular toxicologist and genomic scientist currently serving as Director and Tenured Professor at the Center for Genomics, Loma Linda University. Originally from China, Dr. Wang holds dual graduate degrees in Public Health and Toxicology from Tongji Medical University and the University of Washington, respectively. His early career laid the foundation for pivotal research into environmental toxicants and gene-environment interactions. Dr. Wang has significantly contributed to the understanding of xenobiotic metabolism, DNA methylation, and the transgenerational effects of toxins and epigenetics. His leadership in molecular genetics research is reflected in numerous peer-reviewed publications and competitive grants. A passionate educator and mentor, Dr. Wang’s work bridges foundational science and clinical application, marking him as a strong contender for the Research for Distinguished Scientist Award.

Publication Profile: 

Socpus

Education:

Dr. Wang received his Ph.D. in Toxicology from the University of Washington, Seattle. His doctoral work focused on aflatoxin metabolism and liver glutathione S-transferases in nonhuman primates, mentored by Dr. David L. Eaton. Prior to that, he earned an MPH in Environmental Epidemiology from Tongji Medical University, China, where he developed a foundation in public health and environmental sciences. His dual training in toxicology and epidemiology provided a unique cross-disciplinary approach to health sciences. This strong academic background enables Dr. Wang to address critical questions regarding how environmental exposures affect human health, especially through epigenetic and genomic pathways. His educational path reflects a continuous pursuit of scientific excellence and translational impact, positioning him to bridge molecular discoveries with public health relevance—a crucial quality for a candidate of the Distinguished Scientist Award.

Experience:

Dr. Wang currently serves as Director and Tenured Professor at the Center for Genomics, School of Medicine, Loma Linda University (LLU), where he has led translational and mechanistic genomic research. His responsibilities span academic leadership, mentorship, and collaborative research within the Division of Molecular Genetics. Prior to this, he held the role of Associate Professor-Adjunct in Microbiology & Molecular Genetics at LLU. His earlier roles include postdoctoral and research scientist positions at institutions where he investigated environmental carcinogens, drug metabolism, and gene expression. Over three decades, Dr. Wang has built a multidisciplinary portfolio in toxicology, environmental health, and genomics. He is a leading voice in DNA methylation, epigenetic inheritance, and cancer biology. His integrative research style and administrative skills have allowed him to create impactful programs that foster innovation and interdisciplinary collaboration—an essential trait for any distinguished scientist.

Awards and Honors:

Dr. Wang’s academic journey has been decorated with prestigious accolades from the outset. He received the Excellent Medical Student Award  and Distinguished Graduate Student Award from Tongji Medical University. His pioneering research at the University of Washington earned him the First-Place Graduate Award for Research Excellence from the Society of Toxicology in New Orleans. He was awarded multiple Student Travel Awards from the University of Washington’s School of Public Health. These early recognitions underscore his long-standing commitment to scientific excellence and innovation. Dr. Wang’s later career has been marked by continuous success in publication, grant acquisition, and institutional leadership. These honors reflect both peer recognition and academic merit, reinforcing his status as a credible and outstanding candidate for the Research for Distinguished Scientist Award.

Research Focus:

Dr. Wang’s research focuses on environmental toxicology, genomics, and epigenetics, particularly in the context of transgenerational health effects. He investigates how toxicants such as cadmium, aflatoxin B1, and p,p’-DDE affect gene regulation through epigenetic reprogramming. His lab has pioneered work on DNA methylation, histone modifications, and miRNA signatures in diseases like cancer, neurodevelopmental disorders, and diabetes. Recent work has addressed the effects of e-cigarette exposure on neonatal brain methylomes and the epigenetic inheritance of addiction vulnerability. Dr. Wang also explores copy number variation and drug resistance mechanisms in oncology, using cutting-edge tools like single-cell RNA sequencing and patient-derived models. His integrative, multi-omics approach allows for deep mechanistic insights and clinical translation. His ability to lead multidisciplinary teams in high-impact research areas demonstrates both visionary thinking and the technical prowess necessary for distinguished scientific leadership.

Publications Top Notes:

  1. Cadmium-induced negative calcium balance in multiparous birth women

  2. Effect of cadmium on bone calcium in nonpregnant mice: Direct evidence on bone

  3. Cadmium’s impact on bone calcium in mouse dams: Itai-Itai-like syndrome model

  4. Induction of drug-metabolizing enzymes by BHA, ethoxyquin, and oltipraz

  5. Diquat and ciprofibrate effects on hepatic enzyme expression

  6. Mu-class GSTs mediate aflatoxin B1 epoxide conjugation in Macaca liver

  7. CYP1B1 expression analyzed in human tissues via hybridization techniques

  8. Cloning and characterization of alpha-class GSTs from Macaca liver

  9. Proteomic comparison of hepatocyte preparation methods

  10.  CYP3A41B polymorphism linked to puberty onset and breast cancer risk*

Conclusion:

In conclusion, Dr. Wang’s long-standing academic excellence, innovative research in toxicogenomics, and his leadership in advancing our understanding of environmental and epigenetic factors in disease clearly distinguish him as an outstanding scientist. His achievements fulfill and surpass the expectations for the Research for Distinguished Scientist Award. His profile reflects not only a deep commitment to rigorous science but also a visionary approach to public health and molecular research. With minor expansion in global engagement and translational outreach, Dr. Wang’s impact could be even more far-reaching. He is highly recommended for this honor.

Chao He | Cell Wall Glycosylation | Best Researcher Award

Published on by Cell Biologist

Dr. Chao He | Cell Wall Glycosylation | Best Researcher Award

Dr. Chao He | Anhui University’s School of Life Sciences | China

Dr. Chao He is an accomplished Associate Professor at the School of Life Sciences, Anhui University, China. With a robust background in structural biology and enzymology, his research explores the intersection of microbiology, structural biology, and biotechnology. A Ph.D. graduate from the University of Science and Technology of China, he specializes in carbohydrate-active enzymes and their applications in health and industry. Dr. He has led significant projects funded by the National Natural Science Foundation of China (NSFC) and provincial science agencies. His work elucidates catalytic mechanisms and structural features of glycosyltransferases and glycoside hydrolases, with applications in gut microbiota research and industrial polysaccharide processing. He has authored 17 first/corresponding-author publications in top-tier journals including Nature Synthesis, PNAS, and Angewandte Chemie. His contributions position him as a leading figure in enzymology-driven biotechnological innovation.

Publication Profile: 

Orcid

Education:

Dr. Chao He began his academic journey with a Bachelor of Science in Biomedical Engineering from Southeast University, where he developed a solid foundation in molecular and cellular biology. Motivated to delve deeper into life sciences, he pursued his Ph.D. in Structural Biology at the University of Science and Technology of China (USTC). During his doctoral training, he honed his skills in protein structure analysis, enzyme mechanism elucidation, and X-ray crystallography. His education provided him with cross-disciplinary expertise, combining engineering principles with biological systems. This unique academic blend laid the groundwork for his current research in enzyme discovery and rational design. Dr. He’s academic record reflects his commitment to scientific excellence, critical thinking, and innovation, with early exposure to both theoretical and applied aspects of biomedical sciences—a synergy that continues to inform his research today.

Experience:

Dr. Chao He joined Anhui University as a Lecturer in the School of Life Sciences and was promoted to Associate Professor. Over the past decade, he has led innovative research in enzymology, focusing on glycosyltransferases and hydrolases involved in carbohydrate metabolism. As principal investigator, he manages an NSFC General Program grant, investigating Bacteroides-mediated degradation of polysaccharides, along with multiple provincial-level grants. His lab conducts both basic and applied research, ranging from structural characterization to biocatalytic engineering. Dr. He has extensive experience in high-resolution crystallography, enzyme kinetics, and polysaccharide bioprocessing. He has published 17 high-impact papers and serves as a mentor to graduate and undergraduate students. With a strong academic and technical background, Dr. He is a recognized contributor to the field of molecular enzymology and a reliable collaborator within the broader scientific community.

Research Focus:

Dr. Chao He’s research focuses on understanding the structure-function relationships of carbohydrate-active enzymes (CAZymes), including glycoside hydrolases and glycosyltransferases. He aims to reveal how microbial systems—particularly gut-associated Bacteroides—degrade complex polysaccharides using polysaccharide utilization loci (PULs). His team employs structural biology tools (e.g., X-ray crystallography) and biochemical assays to uncover catalytic mechanisms and binding specificities. This work has major implications in both basic biology and industrial biotechnology, such as the rational engineering of enzymes for improved substrate specificity and thermal stability. Applications include bioconversion of polysaccharides, synthesis of oligosaccharides for prebiotics, and enzyme-based biocatalysis. Dr. He’s integrative approach bridges enzymology, microbiome science, and bioengineering, aligning with global needs in food science, health, and sustainable materials. His research supports enzyme discovery pipelines and contributes to understanding host-microbe interactions via carbohydrate metabolism, thus representing a frontier area in molecular life sciences.

Publications Top Notes: 

  • Biocatalytic enantioselective γ-C–H lactonization of aliphatic carboxylic acids – Nature Synthesis, 2023

  • Specific hydrolysis of curdlan with a novel glycoside hydrolase family 128 β-1,3-endoglucanase containing a carbohydrate-binding module – Carbohydrate Polymers, 2021

  •  Structural basis for histone H3K4me3 recognition by the N-terminal domain of the PHD finger protein Spp1 – Biochemical Journal, 2019

Conclusion:

In conclusion, Dr. Chao He exemplifies the qualities of a top-tier academic researcher whose work contributes significantly to the understanding and application of carbohydrate-active enzymes. His ability to combine structural biology with biotechnology showcases both scientific depth and interdisciplinary innovation. Although there is scope for increasing his outreach and collaborative engagements, his current achievements and research leadership make him a compelling nominee for the Best Researcher Award. His trajectory reflects a researcher who is not only productive and impactful but also poised for continued growth and international recognition.

Yuxin Peng | Cell Adhesion Mechanisms | Best Researcher Award

Published on by Cell Biologist

Prof. Yuxin Peng | Cell Adhesion Mechanisms | Best Researcher Award

Prof. Yuxin Peng | Zhejiang University | China

Dr. Yuxin Peng is a distinguished researcher and educator in the field of biomedical and exercise science engineering. Currently serving as a ZJU 100 Young Professor at Zhejiang University, China, he has made significant strides in developing flexible sensors, smart wearable systems, and human–machine interaction technologies. With a Ph.D. and postdoctoral training at the National University of Singapore, his research integrates cutting-edge materials science, biomechanics, and AI-driven health monitoring systems. His work has been consistently published in high-impact journals like Science Advances, Advanced Science, IEEE Transactions, and Soft Robotics, reflecting both depth and innovation. Dr. Peng’s contributions are not only academic but also practical, with several of his innovations applied in rehabilitation, sports science, and robotics. His dedication and cross-disciplinary expertise make him a strong candidate for recognition such as the Best Researcher Award.

Publication Profiles: 

Orcid
Scopus

Education:

Dr. Yuxin Peng received his doctoral degree (Ph.D.) in an engineering-related discipline, laying a strong foundation in biomedical engineering, biomechanics, and sensor technologies. His early academic pursuits were rooted in multidisciplinary innovation, merging engineering principles with human physiology and robotics. To further deepen his scientific understanding, he pursued postdoctoral research at the prestigious National University of Singapore, focusing on biomedical systems and smart rehabilitation. During his academic training, Dr. Peng built expertise in wearable sensors, motion tracking systems, and soft robotics—technologies that play a crucial role in personalized healthcare and intelligent rehabilitation. His education trajectory demonstrates both depth and diversity, preparing him to address complex biomedical challenges with integrated, high-tech solutions. It also laid the groundwork for his future leadership roles and impactful research career at Zhejiang University, where he now mentors young researchers and leads innovation in health engineering.

Experience:

Dr. Yuxin Peng has built an impressive academic and research career spanning over a decade. He has been a ZJU 100 Young Professor at Zhejiang University, affiliated with the Institute of Exercise Science and Health Engineering. In this role, he leads interdisciplinary research projects in wearable technology, flexible sensors, and human motion analysis. Prior to this, he served as a Research Fellow at the Department of Biomedical Engineering, National University of Singapore, where he focused on intelligent health systems and rehabilitation technologies. His hands-on experience in global, high-tech research environments has allowed him to develop collaborations with experts in robotics, materials science, and medical engineering. He has supervised numerous projects and students, while continuously publishing in high-impact journals. His experience demonstrates a rare blend of academic rigor and real-world application, making him a leader in human-centered biomedical innovation and smart rehabilitation systems.

Research Focus:

Dr. Yuxin Peng’s research focuses on wearable systems, smart sensors, soft robotics, and biomedical signal processing for human motion monitoring and rehabilitation. His work addresses real-world problems such as gait analysis, joint motion detection, force sensing, and rehabilitation assistance. By integrating AI, flexible electronics, and biocompatible materials, he develops high-performance sensors and intelligent exosuits for applications in sports science, elderly care, and physical therapy. Notable innovations include graphene-based aerogels, hydrogel biosensors, and multi-feature neural networks for gesture recognition. His lab has also contributed to optical waveguide sensors, virtual reality rehabilitation, and MI-controlled exoskeletons. The overarching goal of his work is to enable non-invasive, real-time, and personalized health monitoring through smart technology. By pushing the boundaries of soft, adaptive, and human-interactive systems, Dr. Peng’s research is at the forefront of the next generation of intelligent biomedical engineering solutions.

Publications Top Notes:

  1. Hydroplastic Foaming of Graphene Aerogels and AI Tactile Sensors – Science Advances

  2. Underwater Instant Adhesive Hydrogel Interfaces for Robust Biosensing – Advanced Science

  3. Flexible Segmented Assemblable Fiber Optic Sensor for Multi-Joint Monitoring – Soft Robotics (Accepted)

  4. Calibration-Free Optical Waveguide Bending Sensor for Soft Robots – Soft Science

  5. Distributed Plantar 3D Force Measurement System – Sensors and Actuators A

  6. Superelastic Graphene Nanofibrous Aerogels for Intelligent Sign Language – Small

  7. Omnidirectional Soft Bending Sensor for Joint Monitoring – IEEE TIE

  8. Shank-RIO: Ranging-Inertial Odometry for Gait and Positioning – IEEE TIM

  9. Exosuit with Bidirectional Hand Support via Gesture Recognition – IEEE TNSRE

  10.  Advances in Flexible Bending Sensors and Applications – IJ Smart & Nano Materials

Conclusion:

In conclusion, Dr. Yuxin Peng exhibits all the qualities of a top-tier, award-worthy researcher. His work is characterized by scientific rigor, high-impact publication, and a vision for solving real-world healthcare challenges using cutting-edge sensor and robotics technologies. As a respected academic at Zhejiang University with a solid international research background, Dr. Peng has already contributed significantly to wearable health tech and rehabilitation sciences. His ability to combine soft material innovation, artificial intelligence, and biomechanics into novel human-machine interaction systems places him at the forefront of biomedical engineering research. While there is room for growth in the areas of commercialization and global academic engagement, his career trajectory, research excellence, and societal relevance of his innovations make him a highly deserving candidate for the Best Researcher Award.

Jebunnahar Khandakar | Biological Sciences | Best Researcher Award

Published on by Cell Biologist

Dr. Jebunnahar Khandakar | Biological Sciences | Best Researcher Award

Dr. Jebunnahar Khandakar, Independent University, Bangladesh, Bangladesh

Dr. Jebunnahar Khandakar is an accomplished academic and researcher specializing in environmental science, plant physiology, and biotechnology. Currently serving as an Associate Professor in the Department of Life Sciences at Independent University, Bangladesh, she brings extensive expertise in sustainable agriculture and mushroom biotechnology. She earned her PhD from Nagasaki University, Japan, with a focus on plant-environment interactions and proteomics. Over her career, Dr. Khandakar has contributed significantly to research in mushroom cultivation, environmental sustainability, and food system innovations. Her work has been published in renowned journals, reflecting her commitment to developing practical, affordable, and eco-friendly solutions for agricultural improvement. She has also provided consultancy for global initiatives, including work with the UNCCD. Dr. Khandakar’s dedication to research and community impact makes her a strong candidate for recognition as a Best Researcher Award recipient.

Publication Profile: 

Google Scholar

Scopus

Orcid

Education:

Dr. Jebunnahar Khandakar’s educational background demonstrates a strong foundation in biotechnology and environmental science. She earned her Doctor of Philosophy (PhD) in September 2013 from Nagasaki University, Japan, where she focused on plant physiology and biotechnology, specifically analyzing stress responses and secondary metabolism in plants. Prior to that, she completed her MS in Biotechnology in July 2005 from Bangladesh Agricultural University with an excellent academic record (Grade A). Her MS research delved into mycelial growth and spawn production, forming the basis for her long-term interest in fungal biology. These degrees have equipped her with expertise in both applied and fundamental biosciences, particularly in sustainable crop production and biotechnological applications for food and environmental security. Her strong academic background supports her ongoing contributions to science through teaching, mentoring, and pioneering research projects.

Experience:

Dr. Jebunnahar Khandakar has nearly two decades of combined experience in academia and applied environmental science. She is currently an Associate Professor at Independent University, Bangladesh (IUB), where she has served since 2016, being promoted in September 2024. At IUB, she teaches and supervises students in plant biotechnology, environmental biology, and sustainable agriculture. Before her academic tenure, she served as a Junior Consultant for the United Nations Convention to Combat Desertification (UNCCD) at the Department of Environment in Dhaka, where she contributed to policy frameworks for sustainable land use and biodiversity conservation. Her role involved integrating scientific research into national strategies, further enriching her interdisciplinary understanding. Dr. Khandakar’s career trajectory highlights her ability to bridge academic knowledge with field applications, aligning science with real-world agricultural and environmental challenges.

Research Focus:

Dr. Khandakar’s research primarily centers on sustainable agriculture, environmental biotechnology, and fungal physiology. Her work spans optimizing substrates for mushroom cultivation, improving post-harvest shelf life, and exploring biowaste as cultivation media. She also explores molecular and physiological responses of medicinal plants like Hyoscyamus albus under abiotic stresses, including nutrient deficiencies and metal toxicity. Through proteomics and biochemistry, she investigates root signaling, riboflavin biosynthesis, and stress-induced metabolite changes. Recently, her research has shifted to low-cost, eco-friendly solutions for food production—developing nitrogen gas packaging for mushrooms and assessing market chains for semi-fermented fish. Her interdisciplinary approach blends biotechnology with environmental sustainability, aiming to improve nutrition, soil health, and farmer livelihoods. This diverse yet focused research portfolio underlines her impact and innovation in agricultural and life sciences, with clear contributions toward climate-smart and affordable food technologies.

Publications Top Notes: 

  1. Using spent mushroom substrate (SMS) as a casing boosted bacterial activity and enhanced the mineral profile of Calocybe indica.

  2. Deciphering the Role of Substrate C/N Ratio in Preventing Orange Mold Contamination in Mushroom Cultivation.

  3. Establishment of a Simple Single Spore Isolation Method for Gilled Mushroom Research.

  4. Optimizing Tea Waste as a Sustainable Substrate for Oyster Mushroom Cultivation.

  5. Packaging with Nitrogen Gas Enhanced Shelf-Life of Fresh Oyster Mushrooms.

  6. Exploring the Market Value Chain Dynamics of Chepa (Semi-Fermented Fish).

  7. Shelf-life Evaluation of Oyster Mushrooms using Different Packaging Materials and Storage Conditions.

  8. Survey on Technical Efficacy and Farmer Satisfaction for Onion Seed Production in Rajshahi.

  9. Extraction and Fractionation of Subproteome from Hyoscyamus albus Root Tips.

  10.  Reducing Pesticide Use in Cucumber Cultivation via Environment-Friendly Technology.

Conclusion:

Dr. Jebunnahar Khandakar is highly deserving of the Best Researcher Award. Her work is innovative, impactful, and highly aligned with real-world agricultural challenges—particularly in low-cost, sustainable food production methods and environmental biotechnology. She has demonstrated academic excellence, field application, and research leadership over the years, both nationally and internationally.

Rong Zhong | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Rong Zhong | Cancer Cell Biology | Best Researcher Award

Prof. Rong Zhong, Huazhong University of Science and Technology, China

Professor Rong Zhong is an esteemed academic in the field of molecular and cancer epidemiology at Tongji Medical College, Huazhong University of Science and Technology, China. With a PhD in Epidemiology and Biostatistics and postdoctoral training from Harvard Medical School, she has built a distinguished career in investigating genetic and environmental interactions in cancer development. Over the years, she has led 51 research projects, authored 169 peer-reviewed articles, and earned over 3,600 citations. Dr. Zhong’s collaborative work extends across national and international institutions, including Huazhong Agricultural University and the General Hospital of Central Theater Command. Recognized with the Natural Science Award of Hubei Province, she is also actively involved in several national scientific committees. Her commitment to advancing cancer prevention through precision medicine and early detection strategies reflects both her scientific acumen and societal impact, making her a strong candidate for the Best Researcher Award.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Extensive Research Output

    • 169 SCI/Scopus-indexed publications, many in high-impact journals like Gastroenterology, Nature Reviews Clinical Oncology, and Cancer Discovery.

    • Strong citation record with 3,697 citations on Web of Science, reflecting broad scientific influence.

  2. Innovative and Impactful Research

    • Focus on molecular and cancer epidemiology, particularly gene-environment interactions in gastrointestinal cancers, addressing a critical public health challenge.

    • Groundbreaking research on environmental risk factors (e.g., bisphenol A, tobacco smoke) and genetic susceptibility in cancer risk.

  3. Grants and Funding Leadership

    • Principal investigator of major national research projects, including National Natural Science Foundation of China grants and the Young Top-notch Talent Cultivation Program of Hubei Province.

  4. Recognition and Service

    • Recipient of the Natural Science Award of Hubei Province.

    • Serves on editorial boards of reputable journals such as Ebiomedicine and American Journal of Gastroenterology.

    • Active member in national scientific committees related to cancer prevention and epidemiology.

  5. Collaboration and Mentorship

    • Strong institutional and cross-disciplinary collaborations, including with Huazhong Agricultural University and military medical research institutions.

    • A demonstrated leader in mentoring young researchers in public health and biomedical science.

⚙️ Areas for Improvement:

  1. Industry Engagement & Technology Transfer

    • Although she holds 2 patents, there is limited mention of industry consultancy or commercialization, which could strengthen real-world impact.

  2. International Policy Influence

    • Expanding her involvement in international advisory boards or global health policy initiatives could further elevate her research visibility and societal contribution.

  3. Science Communication & Public Engagement

    • Enhanced participation in public education, community outreach, or policy translation could help bridge science and society, especially in preventive oncology.

🎓 Education:

Dr. Rong Zhong earned her PhD in Epidemiology and Biostatistics from the prestigious Huazhong University of Science and Technology, where she built the foundation for her future research excellence. To further expand her academic perspective, she completed postdoctoral training at Harvard Medical School, USA—an experience that enriched her global outlook and enhanced her methodological rigor in public health research. Throughout her academic journey, Dr. Zhong has demonstrated a passion for understanding complex interactions between genes and environmental exposures, particularly in relation to cancer epidemiology. Her education, characterized by a blend of rigorous Chinese academic training and Western research exposure, has laid a strong interdisciplinary base. This robust academic background has equipped her with a unique skill set to lead impactful research in molecular epidemiology and precision prevention of gastrointestinal cancers.

💼 Experience:

Dr. Rong Zhong currently serves as a Professor at the School of Public Health, Tongji Medical College, Huazhong University of Science and Technology. With extensive experience in cancer epidemiology, she has successfully led national and provincial research initiatives including projects funded by the National Natural Science Foundation of China and the Young Top-notch Talent Cultivation Program of Hubei Province. Over the years, she has been instrumental in mentoring young scientists, shaping national health policies, and advancing cancer prevention strategies in China. She also serves on editorial boards of high-impact journals such as Ebiomedicine and American Journal of Gastroenterology. Her experience bridges research, academic leadership, and international collaboration, reflecting her multidimensional contribution to science and public health. Her advisory roles in national committees focused on cancer prevention and epidemiology further underscore her influence and thought leadership in the field.

🔬 Research Focus:

Professor Zhong’s primary research focus lies in molecular and cancer epidemiology, with an emphasis on gastrointestinal cancers. Her work aims to elucidate the gene-environment interactions that contribute to cancer risk, leveraging large-scale cohort and case-control studies. By integrating genomic data with environmental exposures (e.g., diet, pollutants, endocrine-disrupting chemicals), she develops predictive models that enable early screening and personalized prevention strategies for high-risk populations. Her recent studies investigate interactions between genetic polymorphisms and substances like bisphenol A, tobacco smoke, and gut microbiota, especially in relation to colorectal and breast cancer. These contributions bridge the gap between basic science and clinical translation, offering a pathway toward precision public health. Her research not only advances scientific knowledge but also holds tangible implications for national cancer screening guidelines and individualized preventive healthcare strategies.

📚 Publications Top Notes:

  1. 📘 Western-Style Diet, pks Island-Carrying Escherichia coli, and Colorectal Cancer: Analyses From Two Large Prospective Cohort Studies – Gastroenterology

  2. 🚬 In Utero and Childhood/Adolescence Exposure to Tobacco Smoke, Genetic Risk and Lung Cancer Incidence and Mortality in Adulthood – AJRCCM

  3. 🧬 FOXA1 of regulatory variant associated with risk of breast cancer through allele-specific enhancer in the Chinese population – Breast Cancer

  4. 🧪 Genome-wide gene-bisphenol A, F and triclosan interaction analyses on urinary oxidative stress markers – Science of The Total Environment

  5. 🧫 Urinary bisphenol A and its interaction with CYP17A1 rs743572 are associated with breast cancer risk – Chemosphere

  6. 🧠 Animal-eRNAdb: a comprehensive animal enhancer RNA database – Nucleic Acids Research

  7. 🔬 Hepatocellular carcinoma risk variant modulates lncRNA HLA-DQB1-AS1 expression via a long-range enhancer–promoter interaction – Carcinogenesis

  8. 🧍‍♀️ Bisphenol A exposure, interaction with genetic variants and colorectal cancer via mediating oxidative stress biomarkers – Environmental Pollution

  9. 🧾 Discovery and Features of an Alkylating Signature in Colorectal Cancer – Cancer Discovery

  10. 🚨 Rising incidence of early-onset colorectal cancer — a call to action – Nature Reviews Clinical Oncology

📌 Conclusion:

Professor Rong Zhong is an outstanding and highly qualified candidate for the Best Researcher Award. Her prolific output, innovative approaches to cancer risk assessment, and leadership in national scientific research firmly position her among the top-tier researchers in her field. Her contributions have laid the groundwork for precision public health, with real potential to transform early cancer detection and prevention strategies in China and globally.

Veronica Gagliardi | microcirculation | Best Researcher Award

Published on by Cell Biologist

Dr. Veronica Gagliardi | microcirculation | Best Researcher Award

Dr. Veronica Gagliardi, Università degli studi di Padova, Italy

Dr. Veronica Gagliardi is an Italian Medical Doctor specializing in Anaesthesiology, Resuscitation, Intensive Care, and Pain Therapy. Born on August 22, 1996, in Spinea (VE), she is currently undergoing advanced clinical training at the University of Padua, where she has also undertaken a Level II Master in multimodal cardiac imaging. She combines academic excellence with frontline clinical experience in major regional hospitals, including Ospedale dell’Angelo in Mestre and Policlinico Universitario di Padova. Her work focuses on intensive care medicine, advanced echocardiography, and non-invasive ventilation strategies. Dr. Gagliardi is widely published, with a strong record in critical care, pain therapy, and ultrasound techniques. Her proactive involvement in clinical research and innovative therapies, including ECMO and auricular acupuncture, reflects a strong commitment to scientific advancement in patient care. She is a promising researcher and clinician, striving to integrate cutting-edge evidence with compassionate care.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Extensive Research Portfolio:
    Dr. Gagliardi has authored and co-authored over 10 peer-reviewed publications across respected international journals (Life, Medicina, Critical Care, Cureus, EJTM, Arch Clin Biomed Res), covering high-impact areas like ECMO, microcirculation, pain therapy, and non-invasive ventilation.

  2. Clinical-Research Integration:
    Her ability to bridge clinical practice and research is a standout quality. From ECMO and PEEP titration in COVID-19 to auricular electroacupuncture and ultrasound-guided pain procedures, she applies science directly to bedside care.

  3. Strong Academic Record:
    With a Medical Degree cum laude (110/110) and advanced training at the University of Padua, she demonstrates academic excellence, now furthered by a Level II Master in echocardiographic imaging.

  4. Leadership and Collaboration:
    She has actively participated in multi-center projects and international symposia, indicating both team leadership and scientific communication skills.

  5. Innovation and Versatility:
    Her research includes novel and multidisciplinary approaches—like capsaicin patch use for neuropathic pain and auricular diagnostics in oncology contexts.

⚙️ Areas for Improvement:

  1. Recognition and Awards:
    While her work is highly impactful, Dr. Gagliardi may benefit from more formal recognition, such as national/international fellowships, grants, or young investigator awards.

  2. Independent Research Funding:
    Securing her own research grants in the near future would further strengthen her research independence and global visibility.

  3. Broader Dissemination:
    Increasing her presence through conference presentations, keynote talks, or editorial roles would amplify the visibility of her work and boost her academic footprint.

🎓 Education:

Dr. Veronica Gagliardi earned her Master’s Degree in Medicine and Surgery with 110/110 with Honours from the University of Padua, completing an experimental thesis under Prof. Paolo Navalesi on respiratory failure in COVID-19 patients. Since November 2021, she has been enrolled in a five-year residency program in Anaesthesiology, Resuscitation, Intensive Care, and Pain Therapy at the same institution, with rotations in several prominent hospitals. Starting November 2024, she will also undertake a Level II Master (ESTAV) in stress echocardiography, advanced transesophageal, and multimodal cardiac imaging, focusing on perioperative and interventional cardiac ultrasound techniques. Her education reflects not only clinical rigor but also a keen interest in research and innovation, particularly in areas like non-invasive ventilation, ultrasound diagnostics, and pain modulation. Her academic background is complemented by strong scientific output and peer-reviewed contributions in high-impact journals.

💼 Professional Experience:

Dr. Gagliardi has held the role of Medical Doctor specializing in Anaesthesiology and Intensive Care at Ospedale dell’Angelo in Mestre, starting in January 2025. Initially assigned to general anaesthesiology (UOS), she has since progressed to the Cardiac Intensive Care Unit (UOS) from May 2025. Her residency training from November 2021 to January 2025 included rotations in premier institutions such as Policlinico Universitario di Padova, Ospedale S. Antonio, Ospedale Ca’ Foncello, and Ospedale SS Giovanni e Paolo, gaining experience in critical care, pain therapy, perioperative medicine, and emergency interventions. Throughout her career, she has consistently demonstrated clinical versatility, excelling in high-pressure ICU settings. She combines clinical competence with advanced procedural skills, including echocardiography and ultrasound-guided regional blocks. This diverse clinical exposure underpins her contribution to complex case management and patient-centered care.

🏅 Awards and Honors:

Dr. Veronica Gagliardi has not been explicitly listed with specific awards, but her academic and research profile clearly reflects recognition-worthy achievements. She graduated with honors (110/110 cum laude) in Medicine, which stands as an early testament to her dedication and excellence. Her first-author publications in indexed journals, such as Life, Medicina, Critical Care, and EJTM, highlight her as a leading contributor to translational and clinical research in anesthesiology and critical care. Her participation in international symposiums, including the 40th International Symposium on Intensive Care & Emergency Medicine, and collaborations with established experts like Prof. Navalesi, further underscore her growing reputation. While formal honors such as Best Researcher Awards are yet to be listed, her CV is aligned with the standards of excellence and would merit such recognition in academic and clinical research circles.

🔬 Research Focus:

Dr. Gagliardi’s research is deeply rooted in critical care medicine, with a strong emphasis on microcirculation, non-invasive ventilation, pain management, and echocardiographic imaging. Her work spans experimental and clinical domains—from animal models exploring systemic morphine’s anti-inflammatory effects, to human studies on ECMO efficiency and caudal epidural injections. She has delved into innovative diagnostics like diaphragm ultrasound for predicting extubation outcomes, and non-conventional therapies such as auricular electro-acupuncture for microcirculatory modulation. Her research extends into the perioperative and post-operative use of non-invasive respiratory support, and stress echocardiography, bridging imaging and intensive care management. She actively collaborates on multi-center reviews and pilot studies, showing both independence and teamwork. Dr. Gagliardi’s research consistently aims at improving patient outcomes through evidence-based and minimally invasive approaches, contributing significantly to the evolving landscape of modern anaesthesia and critical care.

📚 Publications Top Notes:

📄 The Effects of Levosimendan on Microcirculation and Peripheral Perfusion in Septic Shock: A Pilot Study
📄 Recirculation in Veno-Venous Extracorporeal Membrane Oxygenation
📄 A Possible Correlation Between Auricular Angiomas and Breast Cancer Through Auricular Acupuncture Diagnosis: An Observational Case-Control Study
📄 Ultrasound-guided caudal epidural injection to treat symptoms of lumbar spinal stenosis: a retrospective study
📄 Effects of noninvasive respiratory support in post-operative patients: a systematic review and network meta-analysis
📄 Systemic Morphine but Not Local Administration Shows Preventive Anti-Inflammatory Effect in a Rat Model of Capsaicin-Induced Paw Edema
📄 Effect of Low- and High-Frequency Auricular Stimulation with Electro-Acupuncture on Cutaneous Microcirculation: A Cross-Over Study in Healthy Subjects
📄 Diaphragm Ultrasound: A Valuable Predictor of the Outcome of Extubation. An Observational Pilot Study in Covid-19 Related ARDS
📄 Persistent neuropathic pain treated with Capsaicin patches: a novel promising approach
📄 P101 Execution of percutaneous dilatational tracheostomy using the standard laryngeal mask airway for ventilation: a prospective survey study
📄 Positive end-expiratory pressure titration in COVID-19 acute respiratory failure: electrical impedance tomography vs. PEEP/FiO2 tables

🧾 Conclusion:

Dr. Veronica Gagliardi is an exceptional emerging researcher who combines clinical acumen with a robust scientific mindset. Her research is innovative, clinically relevant, and methodologically sound, spanning critical areas like sepsis management, ECMO, echocardiography, and noninvasive ventilation strategies.